Tandem Diabetes Care, Inc.

Sümbol: TNDM

NASDAQ

35.24

USD

Turuhind täna

-10.3481
P/E suhe
-0.1231
PEG suhe
2.28B
MRK Cap
0.00%
DIV tootlus

Tandem Diabetes Care, Inc. (TNDM) Finantsaruanded

Q: Mis on Tandem Diabetes Care, Inc. (TNDM) koguvara?

Tandem Diabetes Care, Inc. (TNDM) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Tandem Diabetes Care, Inc. (TNDM) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 280.203 M, mis on 1.644 % gowth. Kogu perioodi keskmine brutokasum on 139.675 M, mis on 1.160 %. Keskmine brutokasumi suhtarv on 0.317 %. Ettevõtte eelmise aasta tulemuse puhaskasv on 1.353 %, mis on võrdne -0.632 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Tandem Diabetes Care, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.095. Käibevara valdkonnas on TNDM aruandlusvaluutas 747.989. Märkimisväärne osa neist varadest, täpsemalt 467.912, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust -0.242%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 10.1, kui neid on, aruandlusvaluutas. See näitab erinevust 21.687% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 398.607 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.010%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 313.632 aruandlusvaluutas. Selle aspekti aastane muutus on -0.287%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 105.555, varude hind on 157.94 ja firmaväärtus 0, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 2.78. Kontovõlad ja lühiajalised võlad on vastavalt 49.59 ja 17.06. Koguvõlg on 415.67, netovõlg on 356.8. Muud lühiajalised kohustused moodustavad 84.62, mis lisandub kohustuste kogusummale 639.03. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
balance-sheet.row.cash-and-short-term-investments	1992.9	467.9	616.9	623.8	484.9	176.5	129	14.2	53.5	71.1	67.3	129.5	17.2	8.7
balance-sheet.row.short-term-investments	1595.91	409	444.4	552.6	390.3	125.3	87.2	0.5	8.9	28	36.1	5.1	0	0
balance-sheet.row.net-receivables	395.98	105.6	114.7	110.7	82.2	46.6	35.2	20.8	11.2	14.1	7.7	5.3	2.4	0.2
balance-sheet.row.inventory	580.59	157.9	111.1	68.6	63.7	49.1	19.9	27	21.2	17.5	11.9	10.3	6.3	0.1
balance-sheet.row.other-current-assets	58.89	16.6	7.2	8.4	6.4	4	3.8	2.2	4.2	2.3	1.9	1.8	1.9	0.8
balance-sheet.row.total-current-assets	3028.36	748	850	811.5	637.2	276.1	187.9	64.2	92.1	107	90.8	149	27.8	9.8
balance-sheet.row.property-plant-equipment-net	673.65	164.3	179.2	77.9	69.8	48.5	17.2	19.6	18.4	15.5	12.6	9.9	9	4.2
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	2.78	2.8	4.6	6.6	8.8	0.8	1.1	1.5	1.8	2.1	2.4	2.7	3	0
balance-sheet.row.goodwill-and-intangible-assets	2.78	2.8	4.6	6.6	8.8	0.8	1.1	1.5	1.8	2.1	2.4	2.7	3	0
balance-sheet.row.long-term-investments	20.2	10.1	8.3	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	-10.1	-10.1	-8.3	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	78.5	37.6	19	9.1	0.6	0.7	0.1	10.1	0.1	0.5	0.7	0.6	0	0
balance-sheet.row.total-non-current-assets	765.03	204.7	202.8	93.6	79.2	50	18.4	31.2	20.3	18.1	15.7	13.2	12	4.2
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	3793.39	952.7	1052.8	905.1	716.4	326.1	206.3	95.3	112.4	125.1	106.5	162.2	39.8	14
balance-sheet.row.account-payables	208.04	49.6	55.7	28	17.8	17.7	34.8	22.5	19.3	19.1	14.6	2.4	5.8	0
balance-sheet.row.short-term-debt	68.28	17.1	13.1	9.3	9.4	6.3	0	0	0	0	0	8.1	4.2	12.9
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	1606.27	398.6	406.8	305.4	218.9	14.1	0	76.5	79	29.7	29.4	29.4	0	0
Deferred Revenue Non Current	58.61	13.3	16.9	16.9	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	332.09	84.6	77.6	84.4	70.5	71.5	26.9	11.1	6.9	5.6	2.7	3.7	5.2	3.8
balance-sheet.row.total-non-current-liabilities	1769.59	443.8	447.5	340.2	246.3	31.7	8.7	88.4	86.8	35.1	33.8	32.1	128.8	68.6
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	537.13	130.6	136.6	33.2	25.3	20.4	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	2497.77	639	612.8	472	350.1	131.1	75	124.5	118.3	61.7	51.9	46.7	145.9	85.3
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.26	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-3615.5	-951.8	-729.2	-634.6	-659.2	-624.8	-600.1	-477.6	-404.6	-321.1	-248.7	-169.2	-106.1	-72.7
balance-sheet.row.accumulated-other-comprehensive-income-loss	-2.12	1.4	-1.8	-0.6	0.2	0.1	0	0	0	0	0	-7.6	-5	-3.1
balance-sheet.row.other-total-stockholders-equity	4912.98	1264	1170.9	1068.3	1025.2	819.6	731.3	448.5	398.6	384.6	303.3	292.3	5	4.6
balance-sheet.row.total-stockholders-equity	1295.62	313.6	439.9	433.1	366.3	195	131.3	-29.1	-5.9	63.5	54.6	115.5	-106.1	-71.3
balance-sheet.row.total-liabilities-and-stockholders-equity	3793.39	952.7	1052.8	905.1	716.4	326.1	206.3	95.3	112.4	125.1	106.5	162.2	39.8	14
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	1295.62	313.6	439.9	433.1	366.3	195	131.3	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	3793.39	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	1595.91	409	444.4	552.6	390.3	125.3	87.2	0.5	8.9	28	36.1	5.1	0	0
balance-sheet.row.total-debt	1674.56	415.7	419.9	314.7	228.3	20.4	0	76.5	79	29.7	29.4	29.4	4.2	12.9
balance-sheet.row.net-debt	1277.57	356.8	247.4	243.5	133.7	-30.8	-41.8	62.8	34.3	-13.4	-1.7	-95	-13	4.2

Rahavoogude aruanne

Tandem Diabetes Care, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab -12.104 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 4.18, mis tähistab 1.538 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -85740000.000. See on -3.585 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 15.71, 0, 0, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte 0 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -0.07, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
cash-flows.row.net-income	-222.61	-222.6	-94.6	15.6	-34.4	-24.8	-122.6	-73	-83.4	-72.4	-79.5	-63.1	-33	-25.5
cash-flows.row.depreciation-and-amortization	15.71	15.7	14.3	13.8	10.5	6.1	5.8	6.9	5.5	4.8	4.4	3.2	2	1.3
cash-flows.row.deferred-income-tax	0	9.1	0	4.6	-2.1	15.2	0	-0.2	3.9	0.5	0.3	10.7	-1.3	0.9
cash-flows.row.stock-based-compensation	88.08	88.1	84.9	60.8	58.4	58.1	23.7	12.6	11.7	13.1	15	4.5	0.2	0.3
cash-flows.row.change-in-working-capital	-17.68	-17.7	-4.6	14.4	-36.6	-12.3	8.5	-16.1	0.1	-5	-1.8	-3	-2.5	1
cash-flows.row.account-receivables	4.28	4.3	-7.8	-31	-38.8	-13.7	-15.8	-10.4	2.3	-6.5	-2.5	-3.2	-2.5	0
cash-flows.row.inventory	-46.05	-46.1	-42.5	-5	-15.4	-31	6.8	-5.9	-6.9	-6.1	-1.8	-4.6	-6.3	0
cash-flows.row.account-payables	-4.86	-4.9	24.5	10.3	1.1	8.9	1.6	-2	3.2	3.4	-1.2	0.9	3.6	0
cash-flows.row.other-working-capital	28.95	29	21.1	40	16.5	23.4	15.9	2.2	1.5	4.2	3.8	3.9	2.6	1
cash-flows.row.other-non-cash-items	104.69	95.6	50.5	2.3	28.9	-0.3	76.3	3.7	1.1	0.2	0.3	0	1.1	0.5
cash-flows.row.net-cash-provided-by-operating-activities	-31.81	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-51.6	-51.6	-43	-23.5	-32.3	-19.5	-3	-5.7	-8.9	-5.8	-4.6	-6	-5.5	-1.3
cash-flows.row.acquisitions-net	-69.5	-69.5	-25.7	9.3	4.9	37.4	1.7	0	-10.5	0.1	0.2	0	0	0
cash-flows.row.purchases-of-investments	-510.86	-510.9	-467.7	-733.4	-497.1	-164.6	-123.6	0	-30.6	-80.2	-67.1	-5.1	0	0
cash-flows.row.sales-maturities-of-investments	546.22	546.2	569.5	570	233.3	127.2	35.8	8.5	50	88.5	36.2	0	0	7.2
cash-flows.row.other-investing-activites	65.07	0	0	-9.3	-4.9	-37.4	-1.7	0	10.5	-0.1	-0.2	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-85.74	-85.7	33.2	-186.9	-296.1	-57	-90.7	2.8	10.4	2.4	-35.5	-11.1	-5.5	5.9
cash-flows.row.debt-repayment	0	0	0	0	-244.6	0	-87.7	0	0	0	-30	-4.4	-0.6	0
cash-flows.row.common-stock-issued	6.29	4.2	17.5	51.3	66.9	23.9	172.9	40.4	2.3	68.3	3.7	125.1	0	0.2
cash-flows.row.common-stock-repurchased	-0.54	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	2.31	-0.1	-0.6	0.6	492.2	0.3	32	-8	50	0	30	45.4	48.1	13
cash-flows.row.net-cash-used-provided-by-financing-activities	4.11	4.1	16.9	51.9	314.4	24.2	117.2	32.4	52.3	68.3	3.6	166.1	47.5	13.2
cash-flows.row.effect-of-forex-changes-on-cash	-0.21	-0.2	0.8	0.2	0.4	0.2	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-113.65	-113.6	101.3	-23.4	43.4	9.3	18.1	-31	1.6	11.9	-93.2	107.2	8.5	-2.5
cash-flows.row.cash-at-end-of-period	396.99	58.9	172.5	71.2	94.6	51.2	41.8	13.7	44.7	43.1	31.2	124.4	17.2	8.7
cash-flows.row.cash-at-beginning-of-period	510.64	172.5	71.2	94.6	51.2	41.8	23.7	44.7	43.1	31.2	124.4	17.2	8.7	11.1
cash-flows.row.operating-cash-flow	-31.81	-31.8	50.5	111.4	24.7	41.9	-8.3	-66.1	-61.2	-58.8	-61.4	-47.8	-33.5	-21.5
cash-flows.row.capital-expenditure	-51.6	-51.6	-43	-23.5	-32.3	-19.5	-3	-5.7	-8.9	-5.8	-4.6	-6	-5.5	-1.3
cash-flows.row.free-cash-flow	-83.41	-83.4	7.5	87.8	-7.6	22.4	-11.3	-71.9	-70.1	-64.6	-66	-53.8	-39	-22.9

Kasumiaruande rida

Tandem Diabetes Care, Inc. tulud muutusid võrreldes eelmise perioodiga -0.067%. TNDM brutokasum on teatatud 367.69. Ettevõtte tegevuskulud on 522.17, mille muutus võrreldes eelmise aastaga on 9.978%. Kulud amortisatsioonikulud on 15.71, mis on -0.494% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 522.17, mis näitab 9.978% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -2.773% kasvu võrreldes eelmise aastaga. Tegevustulu on -233.23, mis näitab 2.773% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on 1.353%. Eelmise aasta puhaskasum oli -222.61.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
income-statement-row.row.total-revenue	747.72	747.7	801.2	702.8	498.8	362.3	183.9	107.6	84.2	72.8	49.7	29	2.5	0
income-statement-row.row.cost-of-revenue	380.03	380	388.2	326.6	238.3	168.1	94	63.5	60.7	46.3	34.5	22.8	3.8	0
income-statement-row.row.gross-profit	367.69	367.7	413	376.2	260.5	194.2	89.8	44.1	23.6	26.6	15.2	6.2	-1.3	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	169.67	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	83.8	78.8	0	0	0	-7.9	-77.9	-10.1	-5.4	-3.4	-3.8	44.5	22.7	0
income-statement-row.row.operating-expenses	522.17	522.2	474.8	353.6	268.5	210.9	134.5	107	101.6	95.6	90.9	55.6	31.7	24.2
income-statement-row.row.cost-and-expenses	902.2	902.2	863	680.1	506.8	379	228.5	170.5	162.3	141.9	125.4	78.4	35.5	24.2
income-statement-row.row.interest-income	22.86	22.9	6.1	0.7	1.6	3.3	1.5	0.2	0.3	0.3	0.1	0	0	0
income-statement-row.row.interest-expense	-3.67	7.6	4.3	4.3	12.2	0.1	7.6	11.3	5.7	3.7	3.9	4.7	2.5	0.5
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	12.98	-78.8	-31	7.1	-28.3	-7.9	-77.9	-10.1	-5.4	-3.4	-3.8	-9	2.6	-0.8
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	83.8	78.8	0	0	0	-7.9	-77.9	-10.1	-5.4	-3.4	-3.8	44.5	22.7	0
income-statement-row.row.total-operating-expenses	12.98	-78.8	-31	7.1	-28.3	-7.9	-77.9	-10.1	-5.4	-3.4	-3.8	-9	2.6	-0.8
income-statement-row.row.interest-expense	-3.67	7.6	4.3	4.3	12.2	0.1	7.6	11.3	5.7	3.7	3.9	4.7	2.5	0.5
income-statement-row.row.depreciation-and-amortization	88.47	15.7	31	13.8	10.5	6.1	5.8	6.9	5.5	4.8	4.4	3.2	2	1.3
income-statement-row.row.ebitda-caps	-56.7	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-151.88	-233.2	-61.8	8.8	-8	-16.7	-44.6	-62.9	-78.1	-69	-75.7	-49.4	-33	-24.2
income-statement-row.row.income-before-tax	-220.25	-220.3	-92.9	15.9	-36.3	-24.6	-122.6	-73	-83.5	-72.4	-79.5	-63.1	-33	-25.5
income-statement-row.row.income-tax-expense	2.36	2.4	1.7	0.3	-1.9	0.1	0.1	0	0	0	0.1	4.7	2.5	0.5
income-statement-row.row.net-income	-222.61	-222.6	-94.6	15.6	-34.4	-24.8	-122.6	-73	-83.4	-72.4	-79.5	-63.1	-33	-25.5